Note that some links may require registration or subscription.
In observance of Martin Luther King Day, Morning Break will not be published January 15 and will resume Tuesday January 16.
Last year’s COVID-19 booster reduced the risk of COVID-related thromboembolic events by 47% in older people and by 51% in adults with end stage renal disease, the CDC reported in Morbidity and Mortality Weekly Report (MMWR).
Johns Hopkins Medicine has brought back mandatory masking at all of its Maryland healthcare facilities. (CBS News)
Parents of young children in some states might be shocked to learn that health insurance coverage of hearing aids for children is not universally mandated. (CBS News)
“Good Morning America” co-anchor Michael Strahan and his 19-year-old daughter Isabella opened up about her diagnosis of medulloblastoma, a form of brain cancer. (ABC News)
Meanwhile, cancer specialists remain baffled about the cause(s) of an alarming increase in cancer among younger adults. (Wall Street Journal)
COVID-19 symptoms have changed with the emergence of each new variant. (BBC)
A decade-long decline in blood levels of lead in American Indians has translated into long-term reductions in blood pressure and improved cardiovascular health, according to an NIH-funded study. (Journal of the American Heart Association)
FDA’s new draft guidance on communicating information about the off-label use of drugs and devices has predictably drawn a mixed reaction from interested parties. (Regulatory Focus)
The CDC, which recommends confirmation of a fungal infection before prescribing an antifungal, published a study on nationwide trends in use of prescription antifungal agents, which could inform decisions about how to counteract emerging resistance. (MMWR)
Surgeries to change eye color continue to increase even as ophthalmologists warn of potential risks. (USA Today)
A California appeals court ruled that a lawsuit against Gilead Sciences can go forward; the lawsuit alleges that the company delayed the release of an HIV drug that was safer and more effective than an existing product on the market. (Endpoints News)
A grand jury in Ohio declined to indict a 34-year-old woman for corpse abuse, after she had a home miscarriage and tried to flush the fetus down the toilet. (AP)
As the rate of stillbirths in the U.S. rises, Australia offers a model for dealing with the problem. (ProPublica)
Amazon hopes to expand its Just Walk Out cashier-less technology to hospitals and other healthcare facilities. (CNBC)
Neuralace Medical announced FDA clearance of Axon Therapy, noninvasive peripheral nerve stimulation for chronic painful diabetic neuropathy.
The FDA announced that ResMed has voluntarily recalled the AirFit and AirTouch CPAP masks because of a potential risk of magnetic interference with certain medical devices.
-
Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow
Please enable JavaScript to view the